 | • レポートコード：MRC2-11QY13824 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は血漿トロンボプラスチン前駆物質のグローバル市場について調査・分析したレポートです。種類別（BAY-1213790、BMS-262084、EP-7041、IONIS-FXILRx、その他）市場規模、用途別（心血管、感染症、血栓症、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別血漿トロンボプラスチン前駆物質の競争状況、市場シェア ・世界の血漿トロンボプラスチン前駆物質市場：種類別市場規模 2015年-2020年（BAY-1213790、BMS-262084、EP-7041、IONIS-FXILRx、その他） ・世界の血漿トロンボプラスチン前駆物質市場：種類別市場規模予測 2021年-2026年（BAY-1213790、BMS-262084、EP-7041、IONIS-FXILRx、その他） ・世界の血漿トロンボプラスチン前駆物質市場：用途別市場規模 2015年-2020年（心血管、感染症、血栓症、その他） ・世界の血漿トロンボプラスチン前駆物質市場：用途別市場規模予測 2021年-2026年（心血管、感染症、血栓症、その他） ・北米の血漿トロンボプラスチン前駆物質市場分析：米国、カナダ ・ヨーロッパの血漿トロンボプラスチン前駆物質市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの血漿トロンボプラスチン前駆物質市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の血漿トロンボプラスチン前駆物質市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの血漿トロンボプラスチン前駆物質市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bayer AG、Bristol-Myers Squibb Co、Ionis Pharmaceuticals Inc、Mochida Pharmaceutical Co Ltd、Novartis AG ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Plasma Thromboplastin Antecedent Market
The global Plasma Thromboplastin Antecedent market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Plasma Thromboplastin Antecedent Scope and Market Size
Plasma Thromboplastin Antecedent market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Plasma Thromboplastin Antecedent market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Plasma Thromboplastin Antecedent market is segmented into
BAY-1213790
BMS-262084
EP-7041
IONIS-FXILRx
Others
Segment by Application, the Plasma Thromboplastin Antecedent market is segmented into
Cardiovascular
Infectious Disease
Thrombosis
Others
Regional and Country-level Analysis
The Plasma Thromboplastin Antecedent market is analysed and market size information is provided by regions (countries).
The key regions covered in the Plasma Thromboplastin Antecedent market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Plasma Thromboplastin Antecedent Market Share Analysis
Plasma Thromboplastin Antecedent market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Plasma Thromboplastin Antecedent business, the date to enter into the Plasma Thromboplastin Antecedent market, Plasma Thromboplastin Antecedent product introduction, recent developments, etc.
The major vendors covered:
Bayer AG
Bristol-Myers Squibb Co
Ionis Pharmaceuticals Inc
Mochida Pharmaceutical Co Ltd
Novartis AG
…
1 Study Coverage
1.1 Plasma Thromboplastin Antecedent Product Introduction
1.2 Market Segments
1.3 Key Plasma Thromboplastin Antecedent Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Plasma Thromboplastin Antecedent Market Size Growth Rate by Type
1.4.2 BAY-1213790
1.4.3 BMS-262084
1.4.4 EP-7041
1.4.5 IONIS-FXILRx
1.4.6 Others
1.5 Market by Application
1.5.1 Global Plasma Thromboplastin Antecedent Market Size Growth Rate by Application
1.5.2 Cardiovascular
1.5.3 Infectious Disease
1.5.4 Thrombosis
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Plasma Thromboplastin Antecedent Market Size, Estimates and Forecasts
2.1.1 Global Plasma Thromboplastin Antecedent Revenue 2015-2026
2.1.2 Global Plasma Thromboplastin Antecedent Sales 2015-2026
2.2 Global Plasma Thromboplastin Antecedent, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Plasma Thromboplastin Antecedent Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Plasma Thromboplastin Antecedent Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Plasma Thromboplastin Antecedent Competitor Landscape by Players
3.1 Plasma Thromboplastin Antecedent Sales by Manufacturers
3.1.1 Plasma Thromboplastin Antecedent Sales by Manufacturers (2015-2020)
3.1.2 Plasma Thromboplastin Antecedent Sales Market Share by Manufacturers (2015-2020)
3.2 Plasma Thromboplastin Antecedent Revenue by Manufacturers
3.2.1 Plasma Thromboplastin Antecedent Revenue by Manufacturers (2015-2020)
3.2.2 Plasma Thromboplastin Antecedent Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Plasma Thromboplastin Antecedent Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Plasma Thromboplastin Antecedent Revenue in 2019
3.2.5 Global Plasma Thromboplastin Antecedent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Plasma Thromboplastin Antecedent Price by Manufacturers
3.4 Plasma Thromboplastin Antecedent Manufacturing Base Distribution, Product Types
3.4.1 Plasma Thromboplastin Antecedent Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Plasma Thromboplastin Antecedent Product Type
3.4.3 Date of International Manufacturers Enter into Plasma Thromboplastin Antecedent Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Plasma Thromboplastin Antecedent Market Size by Type (2015-2020)
4.1.1 Global Plasma Thromboplastin Antecedent Sales by Type (2015-2020)
4.1.2 Global Plasma Thromboplastin Antecedent Revenue by Type (2015-2020)
4.1.3 Plasma Thromboplastin Antecedent Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Plasma Thromboplastin Antecedent Market Size Forecast by Type (2021-2026)
4.2.1 Global Plasma Thromboplastin Antecedent Sales Forecast by Type (2021-2026)
4.2.2 Global Plasma Thromboplastin Antecedent Revenue Forecast by Type (2021-2026)
4.2.3 Plasma Thromboplastin Antecedent Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Plasma Thromboplastin Antecedent Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Plasma Thromboplastin Antecedent Market Size by Application (2015-2020)
5.1.1 Global Plasma Thromboplastin Antecedent Sales by Application (2015-2020)
5.1.2 Global Plasma Thromboplastin Antecedent Revenue by Application (2015-2020)
5.1.3 Plasma Thromboplastin Antecedent Price by Application (2015-2020)
5.2 Plasma Thromboplastin Antecedent Market Size Forecast by Application (2021-2026)
5.2.1 Global Plasma Thromboplastin Antecedent Sales Forecast by Application (2021-2026)
5.2.2 Global Plasma Thromboplastin Antecedent Revenue Forecast by Application (2021-2026)
5.2.3 Global Plasma Thromboplastin Antecedent Price Forecast by Application (2021-2026)
6 North America
6.1 North America Plasma Thromboplastin Antecedent by Country
6.1.1 North America Plasma Thromboplastin Antecedent Sales by Country
6.1.2 North America Plasma Thromboplastin Antecedent Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Plasma Thromboplastin Antecedent Market Facts & Figures by Type
6.3 North America Plasma Thromboplastin Antecedent Market Facts & Figures by Application
7 Europe
7.1 Europe Plasma Thromboplastin Antecedent by Country
7.1.1 Europe Plasma Thromboplastin Antecedent Sales by Country
7.1.2 Europe Plasma Thromboplastin Antecedent Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Plasma Thromboplastin Antecedent Market Facts & Figures by Type
7.3 Europe Plasma Thromboplastin Antecedent Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Plasma Thromboplastin Antecedent by Region
8.1.1 Asia Pacific Plasma Thromboplastin Antecedent Sales by Region
8.1.2 Asia Pacific Plasma Thromboplastin Antecedent Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Plasma Thromboplastin Antecedent Market Facts & Figures by Type
8.3 Asia Pacific Plasma Thromboplastin Antecedent Market Facts & Figures by Application
9 Latin America
9.1 Latin America Plasma Thromboplastin Antecedent by Country
9.1.1 Latin America Plasma Thromboplastin Antecedent Sales by Country
9.1.2 Latin America Plasma Thromboplastin Antecedent Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Plasma Thromboplastin Antecedent Market Facts & Figures by Type
9.3 Central & South America Plasma Thromboplastin Antecedent Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Plasma Thromboplastin Antecedent by Country
10.1.1 Middle East and Africa Plasma Thromboplastin Antecedent Sales by Country
10.1.2 Middle East and Africa Plasma Thromboplastin Antecedent Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Plasma Thromboplastin Antecedent Market Facts & Figures by Type
10.3 Middle East and Africa Plasma Thromboplastin Antecedent Market Facts & Figures by Application
11 Company Profiles
11.1 Bayer AG
11.1.1 Bayer AG Corporation Information
11.1.2 Bayer AG Description and Business Overview
11.1.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer AG Plasma Thromboplastin Antecedent Products Offered
11.1.5 Bayer AG Related Developments
11.2 Bristol-Myers Squibb Co
11.2.1 Bristol-Myers Squibb Co Corporation Information
11.2.2 Bristol-Myers Squibb Co Description and Business Overview
11.2.3 Bristol-Myers Squibb Co Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bristol-Myers Squibb Co Plasma Thromboplastin Antecedent Products Offered
11.2.5 Bristol-Myers Squibb Co Related Developments
11.3 Ionis Pharmaceuticals Inc
11.3.1 Ionis Pharmaceuticals Inc Corporation Information
11.3.2 Ionis Pharmaceuticals Inc Description and Business Overview
11.3.3 Ionis Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Ionis Pharmaceuticals Inc Plasma Thromboplastin Antecedent Products Offered
11.3.5 Ionis Pharmaceuticals Inc Related Developments
11.4 Mochida Pharmaceutical Co Ltd
11.4.1 Mochida Pharmaceutical Co Ltd Corporation Information
11.4.2 Mochida Pharmaceutical Co Ltd Description and Business Overview
11.4.3 Mochida Pharmaceutical Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Mochida Pharmaceutical Co Ltd Plasma Thromboplastin Antecedent Products Offered
11.4.5 Mochida Pharmaceutical Co Ltd Related Developments
11.5 Novartis AG
11.5.1 Novartis AG Corporation Information
11.5.2 Novartis AG Description and Business Overview
11.5.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Novartis AG Plasma Thromboplastin Antecedent Products Offered
11.5.5 Novartis AG Related Developments
11.1 Bayer AG
11.1.1 Bayer AG Corporation Information
11.1.2 Bayer AG Description and Business Overview
11.1.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer AG Plasma Thromboplastin Antecedent Products Offered
11.1.5 Bayer AG Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Plasma Thromboplastin Antecedent Market Estimates and Projections by Region
12.1.1 Global Plasma Thromboplastin Antecedent Sales Forecast by Regions 2021-2026
12.1.2 Global Plasma Thromboplastin Antecedent Revenue Forecast by Regions 2021-2026
12.2 North America Plasma Thromboplastin Antecedent Market Size Forecast (2021-2026)
12.2.1 North America: Plasma Thromboplastin Antecedent Sales Forecast (2021-2026)
12.2.2 North America: Plasma Thromboplastin Antecedent Revenue Forecast (2021-2026)
12.2.3 North America: Plasma Thromboplastin Antecedent Market Size Forecast by Country (2021-2026)
12.3 Europe Plasma Thromboplastin Antecedent Market Size Forecast (2021-2026)
12.3.1 Europe: Plasma Thromboplastin Antecedent Sales Forecast (2021-2026)
12.3.2 Europe: Plasma Thromboplastin Antecedent Revenue Forecast (2021-2026)
12.3.3 Europe: Plasma Thromboplastin Antecedent Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Plasma Thromboplastin Antecedent Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Plasma Thromboplastin Antecedent Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Plasma Thromboplastin Antecedent Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Plasma Thromboplastin Antecedent Market Size Forecast by Region (2021-2026)
12.5 Latin America Plasma Thromboplastin Antecedent Market Size Forecast (2021-2026)
12.5.1 Latin America: Plasma Thromboplastin Antecedent Sales Forecast (2021-2026)
12.5.2 Latin America: Plasma Thromboplastin Antecedent Revenue Forecast (2021-2026)
12.5.3 Latin America: Plasma Thromboplastin Antecedent Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Plasma Thromboplastin Antecedent Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Plasma Thromboplastin Antecedent Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Plasma Thromboplastin Antecedent Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Plasma Thromboplastin Antecedent Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Plasma Thromboplastin Antecedent Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Plasma Thromboplastin Antecedent Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Plasma Thromboplastin Antecedent Market Segments
Table 2. Ranking of Global Top Plasma Thromboplastin Antecedent Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Plasma Thromboplastin Antecedent Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of BAY-1213790
Table 5. Major Manufacturers of BMS-262084
Table 6. Major Manufacturers of EP-7041
Table 7. Major Manufacturers of IONIS-FXILRx
Table 8. Major Manufacturers of Others
Table 9. Global Plasma Thromboplastin Antecedent Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Plasma Thromboplastin Antecedent Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Plasma Thromboplastin Antecedent Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Plasma Thromboplastin Antecedent Sales Market Share by Regions (2015-2020)
Table 13. Global Plasma Thromboplastin Antecedent Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Plasma Thromboplastin Antecedent Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Plasma Thromboplastin Antecedent Sales Share by Manufacturers (2015-2020)
Table 16. Global Plasma Thromboplastin Antecedent Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Plasma Thromboplastin Antecedent by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Plasma Thromboplastin Antecedent as of 2019)
Table 18. Plasma Thromboplastin Antecedent Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Plasma Thromboplastin Antecedent Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Plasma Thromboplastin Antecedent Price (2015-2020) (USD/Pcs)
Table 21. Plasma Thromboplastin Antecedent Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Plasma Thromboplastin Antecedent Product Type
Table 23. Date of International Manufacturers Enter into Plasma Thromboplastin Antecedent Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Plasma Thromboplastin Antecedent Sales by Type (2015-2020) (K Pcs)
Table 26. Global Plasma Thromboplastin Antecedent Sales Share by Type (2015-2020)
Table 27. Global Plasma Thromboplastin Antecedent Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Plasma Thromboplastin Antecedent Revenue Share by Type (2015-2020)
Table 29. Plasma Thromboplastin Antecedent Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Plasma Thromboplastin Antecedent Sales by Application (2015-2020) (K Pcs)
Table 31. Global Plasma Thromboplastin Antecedent Sales Share by Application (2015-2020)
Table 32. North America Plasma Thromboplastin Antecedent Sales by Country (2015-2020) (K Pcs)
Table 33. North America Plasma Thromboplastin Antecedent Sales Market Share by Country (2015-2020)
Table 34. North America Plasma Thromboplastin Antecedent Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Plasma Thromboplastin Antecedent Revenue Market Share by Country (2015-2020)
Table 36. North America Plasma Thromboplastin Antecedent Sales by Type (2015-2020) (K Pcs)
Table 37. North America Plasma Thromboplastin Antecedent Sales Market Share by Type (2015-2020)
Table 38. North America Plasma Thromboplastin Antecedent Sales by Application (2015-2020) (K Pcs)
Table 39. North America Plasma Thromboplastin Antecedent Sales Market Share by Application (2015-2020)
Table 40. Europe Plasma Thromboplastin Antecedent Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Plasma Thromboplastin Antecedent Sales Market Share by Country (2015-2020)
Table 42. Europe Plasma Thromboplastin Antecedent Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Plasma Thromboplastin Antecedent Revenue Market Share by Country (2015-2020)
Table 44. Europe Plasma Thromboplastin Antecedent Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Plasma Thromboplastin Antecedent Sales Market Share by Type (2015-2020)
Table 46. Europe Plasma Thromboplastin Antecedent Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Plasma Thromboplastin Antecedent Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Plasma Thromboplastin Antecedent Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Plasma Thromboplastin Antecedent Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Plasma Thromboplastin Antecedent Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Plasma Thromboplastin Antecedent Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Plasma Thromboplastin Antecedent Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Plasma Thromboplastin Antecedent Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Plasma Thromboplastin Antecedent Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Plasma Thromboplastin Antecedent Sales Market Share by Application (2015-2020)
Table 56. Latin America Plasma Thromboplastin Antecedent Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Plasma Thromboplastin Antecedent Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Plasma Thromboplastin Antecedent Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Plasma Thromboplastin Antecedent Revenue Market Share by Country (2015-2020)
Table 60. Latin America Plasma Thromboplastin Antecedent Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Plasma Thromboplastin Antecedent Sales Market Share by Type (2015-2020)
Table 62. Latin America Plasma Thromboplastin Antecedent Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Plasma Thromboplastin Antecedent Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Plasma Thromboplastin Antecedent Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Plasma Thromboplastin Antecedent Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Plasma Thromboplastin Antecedent Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Plasma Thromboplastin Antecedent Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Plasma Thromboplastin Antecedent Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Plasma Thromboplastin Antecedent Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Plasma Thromboplastin Antecedent Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Plasma Thromboplastin Antecedent Sales Market Share by Application (2015-2020)
Table 72. Bayer AG Corporation Information
Table 73. Bayer AG Description and Major Businesses
Table 74. Bayer AG Plasma Thromboplastin Antecedent Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Bayer AG Product
Table 76. Bayer AG Recent Development
Table 77. Bristol-Myers Squibb Co Corporation Information
Table 78. Bristol-Myers Squibb Co Description and Major Businesses
Table 79. Bristol-Myers Squibb Co Plasma Thromboplastin Antecedent Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Bristol-Myers Squibb Co Product
Table 81. Bristol-Myers Squibb Co Recent Development
Table 82. Ionis Pharmaceuticals Inc Corporation Information
Table 83. Ionis Pharmaceuticals Inc Description and Major Businesses
Table 84. Ionis Pharmaceuticals Inc Plasma Thromboplastin Antecedent Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Ionis Pharmaceuticals Inc Product
Table 86. Ionis Pharmaceuticals Inc Recent Development
Table 87. Mochida Pharmaceutical Co Ltd Corporation Information
Table 88. Mochida Pharmaceutical Co Ltd Description and Major Businesses
Table 89. Mochida Pharmaceutical Co Ltd Plasma Thromboplastin Antecedent Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Mochida Pharmaceutical Co Ltd Product
Table 91. Mochida Pharmaceutical Co Ltd Recent Development
Table 92. Novartis AG Corporation Information
Table 93. Novartis AG Description and Major Businesses
Table 94. Novartis AG Plasma Thromboplastin Antecedent Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Novartis AG Product
Table 96. Novartis AG Recent Development
Table 97. Global Plasma Thromboplastin Antecedent Sales Forecast by Regions (2021-2026) (K Pcs)
Table 98. Global Plasma Thromboplastin Antecedent Sales Market Share Forecast by Regions (2021-2026)
Table 99. Global Plasma Thromboplastin Antecedent Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 100. Global Plasma Thromboplastin Antecedent Revenue Market Share Forecast by Regions (2021-2026)
Table 101. North America: Plasma Thromboplastin Antecedent Sales Forecast by Country (2021-2026) (K Pcs)
Table 102. North America: Plasma Thromboplastin Antecedent Revenue Forecast by Country (2021-2026) (US$ Million)
Table 103. Europe: Plasma Thromboplastin Antecedent Sales Forecast by Country (2021-2026) (K Pcs)
Table 104. Europe: Plasma Thromboplastin Antecedent Revenue Forecast by Country (2021-2026) (US$ Million)
Table 105. Asia Pacific: Plasma Thromboplastin Antecedent Sales Forecast by Region (2021-2026) (K Pcs)
Table 106. Asia Pacific: Plasma Thromboplastin Antecedent Revenue Forecast by Region (2021-2026) (US$ Million)
Table 107. Latin America: Plasma Thromboplastin Antecedent Sales Forecast by Country (2021-2026) (K Pcs)
Table 108. Latin America: Plasma Thromboplastin Antecedent Revenue Forecast by Country (2021-2026) (US$ Million)
Table 109. Middle East and Africa: Plasma Thromboplastin Antecedent Sales Forecast by Country (2021-2026) (K Pcs)
Table 110. Middle East and Africa: Plasma Thromboplastin Antecedent Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 112. Key Challenges
Table 113. Market Risks
Table 114. Main Points Interviewed from Key Plasma Thromboplastin Antecedent Players
Table 115. Plasma Thromboplastin Antecedent Customers List
Table 116. Plasma Thromboplastin Antecedent Distributors List
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Plasma Thromboplastin Antecedent Product Picture
Figure 2. Global Plasma Thromboplastin Antecedent Sales Market Share by Type in 2020 & 2026
Figure 3. BAY-1213790 Product Picture
Figure 4. BMS-262084 Product Picture
Figure 5. EP-7041 Product Picture
Figure 6. IONIS-FXILRx Product Picture
Figure 7. Others Product Picture
Figure 8. Global Plasma Thromboplastin Antecedent Sales Market Share by Application in 2020 & 2026
Figure 9. Cardiovascular
Figure 10. Infectious Disease
Figure 11. Thrombosis
Figure 12. Others
Figure 13. Plasma Thromboplastin Antecedent Report Years Considered
Figure 14. Global Plasma Thromboplastin Antecedent Market Size 2015-2026 (US$ Million)
Figure 15. Global Plasma Thromboplastin Antecedent Sales 2015-2026 (K Pcs)
Figure 16. Global Plasma Thromboplastin Antecedent Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Plasma Thromboplastin Antecedent Sales Market Share by Region (2015-2020)
Figure 18. Global Plasma Thromboplastin Antecedent Sales Market Share by Region in 2019
Figure 19. Global Plasma Thromboplastin Antecedent Revenue Market Share by Region (2015-2020)
Figure 20. Global Plasma Thromboplastin Antecedent Revenue Market Share by Region in 2019
Figure 21. Global Plasma Thromboplastin Antecedent Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Plasma Thromboplastin Antecedent Revenue in 2019
Figure 23. Plasma Thromboplastin Antecedent Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Plasma Thromboplastin Antecedent Sales Market Share by Type (2015-2020)
Figure 25. Global Plasma Thromboplastin Antecedent Sales Market Share by Type in 2019
Figure 26. Global Plasma Thromboplastin Antecedent Revenue Market Share by Type (2015-2020)
Figure 27. Global Plasma Thromboplastin Antecedent Revenue Market Share by Type in 2019
Figure 28. Global Plasma Thromboplastin Antecedent Market Share by Price Range (2015-2020)
Figure 29. Global Plasma Thromboplastin Antecedent Sales Market Share by Application (2015-2020)
Figure 30. Global Plasma Thromboplastin Antecedent Sales Market Share by Application in 2019
Figure 31. Global Plasma Thromboplastin Antecedent Revenue Market Share by Application (2015-2020)
Figure 32. Global Plasma Thromboplastin Antecedent Revenue Market Share by Application in 2019
Figure 33. North America Plasma Thromboplastin Antecedent Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Plasma Thromboplastin Antecedent Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Plasma Thromboplastin Antecedent Sales Market Share by Country in 2019
Figure 36. North America Plasma Thromboplastin Antecedent Revenue Market Share by Country in 2019
Figure 37. U.S. Plasma Thromboplastin Antecedent Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Plasma Thromboplastin Antecedent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Plasma Thromboplastin Antecedent Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Plasma Thromboplastin Antecedent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Plasma Thromboplastin Antecedent Market Share by Type in 2019
Figure 42. North America Plasma Thromboplastin Antecedent Market Share by Application in 2019
Figure 43. Europe Plasma Thromboplastin Antecedent Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe Plasma Thromboplastin Antecedent Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Plasma Thromboplastin Antecedent Sales Market Share by Country in 2019
Figure 46. Europe Plasma Thromboplastin Antecedent Revenue Market Share by Country in 2019
Figure 47. Germany Plasma Thromboplastin Antecedent Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany Plasma Thromboplastin Antecedent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Plasma Thromboplastin Antecedent Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France Plasma Thromboplastin Antecedent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Plasma Thromboplastin Antecedent Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. Plasma Thromboplastin Antecedent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Plasma Thromboplastin Antecedent Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy Plasma Thromboplastin Antecedent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Plasma Thromboplastin Antecedent Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia Plasma Thromboplastin Antecedent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Plasma Thromboplastin Antecedent Market Share by Type in 2019
Figure 58. Europe Plasma Thromboplastin Antecedent Market Share by Application in 2019
Figure 59. Asia Pacific Plasma Thromboplastin Antecedent Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Plasma Thromboplastin Antecedent Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Plasma Thromboplastin Antecedent Sales Market Share by Region in 2019
Figure 62. Asia Pacific Plasma Thromboplastin Antecedent Revenue Market Share by Region in 2019
Figure 63. China Plasma Thromboplastin Antecedent Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Plasma Thromboplastin Antecedent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Plasma Thromboplastin Antecedent Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Plasma Thromboplastin Antecedent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Plasma Thromboplastin Antecedent Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Plasma Thromboplastin Antecedent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Plasma Thromboplastin Antecedent Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Plasma Thromboplastin Antecedent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Plasma Thromboplastin Antecedent Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Plasma Thromboplastin Antecedent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Plasma Thromboplastin Antecedent Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Plasma Thromboplastin Antecedent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Plasma Thromboplastin Antecedent Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Plasma Thromboplastin Antecedent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Plasma Thromboplastin Antecedent Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Plasma Thromboplastin Antecedent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Plasma Thromboplastin Antecedent Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Plasma Thromboplastin Antecedent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Plasma Thromboplastin Antecedent Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Plasma Thromboplastin Antecedent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Plasma Thromboplastin Antecedent Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Plasma Thromboplastin Antecedent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Plasma Thromboplastin Antecedent Market Share by Type in 2019
Figure 86. Asia Pacific Plasma Thromboplastin Antecedent Market Share by Application in 2019
Figure 87. Latin America Plasma Thromboplastin Antecedent Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Plasma Thromboplastin Antecedent Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Plasma Thromboplastin Antecedent Sales Market Share by Country in 2019
Figure 90. Latin America Plasma Thromboplastin Antecedent Revenue Market Share by Country in 2019
Figure 91. Mexico Plasma Thromboplastin Antecedent Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Plasma Thromboplastin Antecedent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Plasma Thromboplastin Antecedent Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Plasma Thromboplastin Antecedent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Plasma Thromboplastin Antecedent Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Plasma Thromboplastin Antecedent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Plasma Thromboplastin Antecedent Market Share by Type in 2019
Figure 98. Latin America Plasma Thromboplastin Antecedent Market Share by Application in 2019
Figure 99. Middle East and Africa Plasma Thromboplastin Antecedent Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Plasma Thromboplastin Antecedent Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Plasma Thromboplastin Antecedent Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Plasma Thromboplastin Antecedent Revenue Market Share by Country in 2019
Figure 103. Turkey Plasma Thromboplastin Antecedent Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Plasma Thromboplastin Antecedent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Plasma Thromboplastin Antecedent Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Plasma Thromboplastin Antecedent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Plasma Thromboplastin Antecedent Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Plasma Thromboplastin Antecedent Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Plasma Thromboplastin Antecedent Market Share by Type in 2019
Figure 110. Middle East and Africa Plasma Thromboplastin Antecedent Market Share by Application in 2019
Figure 111. North America Plasma Thromboplastin Antecedent Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America Plasma Thromboplastin Antecedent Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Plasma Thromboplastin Antecedent Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe Plasma Thromboplastin Antecedent Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Plasma Thromboplastin Antecedent Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific Plasma Thromboplastin Antecedent Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Plasma Thromboplastin Antecedent Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America Plasma Thromboplastin Antecedent Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Plasma Thromboplastin Antecedent Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa Plasma Thromboplastin Antecedent Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
血漿プロテアーゼC1阻害剤治療の世界市場（～2026年） This report on the plasma protease C1-inhibitors treatment market analyzes the current and future scenario of the global market. Large number of acute HAE patients is increasing the usage of plasma protease C1-inhibitors treatment. Increasing prevalence of rare diseases around the world, promising p…- プラズマアーク切断の世界市場（～2026年） Market Analysis and Insights: Global Plasma Arc Cutting Market The global Plasma Arc Cutting market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes…
- 血漿分画の世界市場（～2026年） Blood plasma fractionation refers to the general processes of separating the various components of blood plasma, which in turn is a component of blood obtained through blood fractionation. Increasing awareness about the disease and increasing disposable income are expected to boost the growth of the…
- 血漿成分分離器の世界市場（～2026年） Plasma are generally used to increase blood volume or it can be separated into individual plasma proteins such as fibrinogen, factor VIII, anti-thrombin III and factor IX. Improving healthcare infrastructure is expected to boost the growth of the plasma component separator market. Market Analysis an…
- ヒト血漿由来治療薬の世界市場（～2026年） Market Analysis and Insights: Global Human Plasma-Derived Therapeutics Market The global Human Plasma-Derived Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Human Plasma-Derived Therapeutics Scope and Mar…